Literature DB >> 31520365

Deletion of the Creatine Transporter (Slc6a8) in Dopaminergic Neurons Leads to Hyperactivity in Mice.

Zuhair I Abdulla1,2, Bahar Pahlevani1, Kerstin H Lundgren3, Jordan L Pennington1, Kenea C Udobi1,2, Kim B Seroogy3,2, Matthew R Skelton4,5.   

Abstract

The lack of cerebral creatine (Cr) causes intellectual disability and epilepsy. In addition, a significant portion of individuals with Cr transporter (Crt) deficiency (CTD), the leading cause of cerebral Cr deficiency syndromes (CCDS), are diagnosed with attention-deficit hyperactivity disorder. While the neurological effects of CTD are clear, the mechanisms that underlie these deficits are unknown. Part of this is due to the heterogenous nature of the brain and the unique metabolic demands of specific neuronal systems. Of particular interest related to Cr physiology are dopaminergic neurons, as many CCDS patients have ADHD and Cr has been implicated in dopamine-associated neurodegenerative disorders, such as Parkinson's and Huntington's diseases. The purpose of this study was to examine the effect of a loss of the Slc6a8 (Crt) gene in dopamine transporter (Slc6a3; DAT) expressing cells on locomotor activity and motor function as the mice age. Floxed Slc6a8 (Slc6a8flox) mice were mated to DATIREScre expressing mice to generate DAT-specific Slc6a8 knockouts (dCrt-/y). Locomotor activity, spontaneous activity, and performance in the challenging beam test were evaluated monthly in dCrt-/y and control (Slc6a8flox) mice from 3 to 12 months of age. dCrt-/y mice were hyperactive compared with controls throughout testing. In addition, dCrt-/y mice showed increased rearing and hindlimb steps in the spontaneous activity test. Latency to cross the narrow bridge was increased in dCrt-/y mice while foot slips were unchanged. Taken together, these data suggest that the lack of Cr in dopaminergic neurons causes hyperactivity while sparing motor function.

Entities:  

Keywords:  Creatine; Creatine transporter; DAT-Cre; Hyperactivity; Motor function

Mesh:

Substances:

Year:  2019        PMID: 31520365      PMCID: PMC7001766          DOI: 10.1007/s12031-019-01405-w

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  38 in total

1.  Creatine and cyclocreatine attenuate MPTP neurotoxicity.

Authors:  R T Matthews; R J Ferrante; P Klivenyi; L Yang; A M Klein; G Mueller; R Kaddurah-Daouk; M F Beal
Journal:  Exp Neurol       Date:  1999-05       Impact factor: 5.330

2.  Dodecyl creatine ester-loaded nanoemulsion as a promising therapy for creatine transporter deficiency.

Authors:  Gabriela Ullio-Gamboa; Kenea C Udobi; Sophie Dezard; Marla K Perna; Keila N Miles; Narciso Costa; Frédéric Taran; Alain Pruvost; Jean-Pierre Benoit; Matthew R Skelton; Pascale de Lonlay; Aloïse Mabondzo
Journal:  Nanomedicine (Lond)       Date:  2019-04-30       Impact factor: 5.307

3.  Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi and olfactory tubercle on feeding, locomotor activity, and amphetamine anorexia in the rat.

Authors:  G F Koob; S J Riley; S C Smith; T W Robbins
Journal:  J Comp Physiol Psychol       Date:  1978-10

4.  Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect?

Authors:  K M Cecil; G S Salomons; W S Ball; B Wong; G Chuck; N M Verhoeven; C Jakobs; T J DeGrauw
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

5.  Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging.

Authors:  Amy Newmeyer; Kim M Cecil; Mark Schapiro; Joseph F Clark; Ton J Degrauw
Journal:  J Dev Behav Pediatr       Date:  2005-08       Impact factor: 2.225

6.  VGLUT2 in dopamine neurons is required for psychostimulant-induced behavioral activation.

Authors:  Carolina Birgner; Karin Nordenankar; Martin Lundblad; José Alfredo Mendez; Casey Smith; Madeleine le Grevès; Dagmar Galter; Lars Olson; Anders Fredriksson; Louis-Eric Trudeau; Klas Kullander; Asa Wallén-Mackenzie
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

7.  Creatine transporter knockout mice (Slc6a8) show increases in serotonin-related proteins and are resilient to learned helplessness.

Authors:  Zuhair I Abdulla; Jordan L Pennington; Arnold Gutierrez; Matthew R Skelton
Journal:  Behav Brain Res       Date:  2019-09-19       Impact factor: 3.332

8.  Female mice heterozygous for creatine transporter deficiency show moderate cognitive deficits.

Authors:  Emily R Hautman; Amanda N Kokenge; Kenea C Udobi; Michael T Williams; Charles V Vorhees; Matthew R Skelton
Journal:  J Inherit Metab Dis       Date:  2013-05-29       Impact factor: 4.982

9.  Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: Involvement of intracellular signaling pathways.

Authors:  M P Cunha; M D Martín-de-Saavedra; A Romero; E Parada; J Egea; L Del Barrio; A L S Rodrigues; M G López
Journal:  Neuroscience       Date:  2013-02-26       Impact factor: 3.590

10.  Effect of bilateral 6-OHDA lesions of the substantia nigra on locomotor activity in the rat.

Authors:  K Sakai; D M Gash
Journal:  Brain Res       Date:  1994-01-07       Impact factor: 3.252

View more
  4 in total

Review 1.  The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development.

Authors:  Elsa Ghirardini; Francesco Calugi; Giulia Sagona; Federica Di Vetta; Martina Palma; Roberta Battini; Giovanni Cioni; Tommaso Pizzorusso; Laura Baroncelli
Journal:  Genes (Basel)       Date:  2021-07-24       Impact factor: 4.096

2.  A new rat model of creatine transporter deficiency reveals behavioral disorder and altered brain metabolism.

Authors:  Lara Duran-Trio; Gabriella Fernandes-Pires; Dunja Simicic; Jocelyn Grosse; Clothilde Roux-Petronelli; Stephen J Bruce; Pierre-Alain Binz; Carmen Sandi; Cristina Cudalbu; Olivier Braissant
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379

Review 3.  Attention-deficit/hyperactive disorder updates.

Authors:  Miriam Kessi; Haolin Duan; Juan Xiong; Baiyu Chen; Fang He; Lifen Yang; Yanli Ma; Olumuyiwa A Bamgbade; Jing Peng; Fei Yin
Journal:  Front Mol Neurosci       Date:  2022-09-21       Impact factor: 6.261

Review 4.  The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome.

Authors:  Clemens V Farr; Ali El-Kasaby; Michael Freissmuth; Sonja Sucic
Journal:  Front Synaptic Neurosci       Date:  2020-10-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.